PMID: 42020366
Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia.
Yuan Lunzhi, Xiao Haiqing, Liu Xuan, Zhou Ming, Zhang Chang, Wu Kun, Ye Jianghui, Zhang Longmei, Li Xinglin, Ma Jian
Signal transduction and targeted therapy · 2026
Vol. 11, Issue 1
This entry links to third-party literature. For research use only.
AnimalsMaleFemaleDrug RepositioningTestosteroneCOVID-19SARS-CoV-2COVID-19 Drug TreatmentFinasterideSex Characteristics